Show Side Menu
To view, print or save our practice booklet, click here


Oxford AstraZeneca vaccine

New guidance has been issued for the use of the Oxford AstraZeneca Covid-19 vaccine.

This follows further reviews by the independent regulator, the MHRA, and the Commission for Human Medicines, of a very small number of people in the UK who have developed a rare blood-clotting condition since having the Oxford AstraZeneca Covid-19 vaccine.

The MHRA and Joint Committee for Vaccinations and Immunisations have emphasised that the risk of this condition is extremely small and that the benefits of the vaccine outweigh the risks for the vast majority of people.  They have recommended that:

  • Everyone who has had the AstraZeneca vaccine should still have a second dose of the AstraZeneca vaccine, irrespective of age, unless they have had a blood clot or have an existing risk of thrombosis (blood clotting)
  • People aged 30 and over or who have a health condition that puts them at higher risk of severe Covid-19 disease should still be offered the Oxford AstraZeneca vaccine.  The benefits in protecting them against the serious consequences of COVID-19 outweigh any risk of this rare condition.
  • People aged 18-29 who do not have a health condition that puts them at higher risk of severe Covid-19 disease will be offered an alternative Covid-19 vaccine where available.  (This has been recommended as a precaution as people under 30 are at less risk from Covid-19 and not because they are considered to be at particular risk of developing the rare blood clot.)
  • People under 30 can still choose to have the Oxford AstraZeneca vaccine if this will mean they can be protected more quickly and they have been made aware of the guidance.

Please see the leaflet below that has been produced by Public Health England and the NHS to answer any questions you may have

Leaflet on COVID-19 vaccination and blood clotting (EXTERNAL LINK)

The staff at the Practice are working towards completing the vaccination programme, first and second doses, for all our patients in cohorts 1-9. However to enable the practice to restore clinical services that were reduced due to the pandemic, the decision has been taken that we will not participate in the vaccination programme for our patients in cohorts 10-12 , those aged 40-49, 30-39 and 18-29. If you are in one of these cohorts, please wait for your invitation from NHS England to book your vaccinations at a mass vaccination site or pharmacy.

We understand that many of our patients will want to know about COVID-19 vaccinations.

Vaccines will be offered from a number of different locations to make sure everyone who needs a vaccine is able to get one. At the moment, we do not have any information about where these will be or when but we will share these details with patients as soon as we know.

Current guidance states that the vaccine will be offered to those most at risk from COVID19 first, starting with people living in care homes and those over 80 years old. The guidance then states that the vaccine should then be offered to people with high or medium risk clinical conditions and those aged between 50 and 80. For further information about who will be offered a vaccine, please see the guidance from the Joint Committee for Vaccinations and Immunisations which is available on the website.

Our phone lines are extremely busy at the moment. Please could we kindly ask you not to contact the practice for information about the vaccine as there is not currently any further information available. Please keep our phone lines free for those patients who need urgent help.

We will continue to update our website as and when we have more information. Thank you for your patience and understanding.



Your Neighbourhood Professionals. Just a Click Away!